Session Details

[O3]Oral Presentations 3

Tue. Mar 3, 2026 9:45 AM - 10:45 AM JST
Tue. Mar 3, 2026 12:45 AM - 1:45 AM UTC
Kobe Portopia Hotel(South Wing 1F Ohwada)
【R&D II&III】

[O3-01]Development of Next-Generation Subunit Vaccines Using Adeno-Associated Virus Vectors

*Takashi OKADA1 (1. The Institute of Medical Science, The University of Tokyo (Japan))
Comment()

[O3-02]Tissue inflammatory memory drives intractable chronic inflammatory diseases

*Kiyoshi Hirahara1,2 (1. Department of Immunology, Graduate School of Medicine, Chiba University (Japan), 2. cSIMVa, Chiba University (Japan))
Comment()

[O3-03]Monitoring of high pathogenicity avian influenza viruses in wildlife

*Takahiro Hiono1,2,3,4, Naganori Nao1,3,4, Yukiko Watanabe5, Masahiro Toyama6, Kaoru Hattori7, Keita Matsuno1,3,4, Norikazu Isoda1,2,3,4, Manabu Onuma8, Yoshihiro Sakoda1,2,3,4 (1. One Health Research Center, Hokkaido University (Japan), 2. Laboratory of Microbiology, Faculty of Veterinary Medicine, Hokkaido University (Japan), 3. International Institute for Zoonosis Control, Hokkaido University (Japan), 4. Hokkaido University Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University (Japan), 5. Institute for Raptor Biomedicine Japan (Japan), 6. Nemuro City Museum of History and Nature (Japan), 7. Fisheries Resources Institute, Japan Fisheries Research and Education Agency (Japan), 8. National Institute for Environmental Studies (Japan))
Comment()

[O3-04]Development of a germ-free marmoset experimental platform as a non-human primate model for recapitulating the human microbiota

*Takashi Inoue1, Kenya Sato1, Koji Atarashi2, Takeshi Tanoue2, Kozue Takeshita2, Wataru Suda3, Emi Sasaki1, Eiko Yamazaki1, Jinsho Aoki4, Shiori Yamazaki4, Ayako Y Murayama1, Ryoko Nozu5, Yuyo Ka5, Kayo Tomiyama5, Fumiko Seki6, Kazumasa Fukasawa4, Riichi Takahashi5, Makoto Suematsu6, Kenya Honda2, Erika Sasaki1 (1. Department of Biological Functions and Regulation, Central Institute for Experimental Medicine and Life Science (Japan), 2. Department of Microbiology and Immunology, Keio University School of Medicine (Japan), 3. Laboratory for Symbiotic Microbiome Sciences, RIKEN Center for Integrative Medical Sciences (Japan), 4. Yaotsu Breeding Center, CLEA Japan, Inc (Japan), 5. Animal Resource & Technical Research Center, Central Institute for Experimental Medicine and Life Science (Japan), 6. Bioimaging Center, Central Institute for Experimental Medicine and Life Science (Japan))
Comment()

[O3-05]Tackling AMR in protozoan parasites

*Cevayir Coban1 (1. IMSUT, UTOPIA, The University of Tokyo (Jersey))
Comment()

[O3-06E]The pyruvate-GPR31 signaling promotes transepithelial dendrite formation in human intestinal dendritic cells

*Eri Igashira1, Mari Murakami1,2, Kiyoshi Takeda1,2,3,4,5 (1. Laboratory of Immune Regulation, Graduate School of Medicine, The University of Osaka (Japan), 2. WPI Immunology Frontier Research Center, The University of Osaka (Japan), 3. Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka (Japan), 4. Center for Infectious Disease Education and Research, The University of Osaka (Japan), 5. Center for Advanced Modalities and DDS (CAMaD), The University of Osaka (Japan))
Comment()